Rare diseases
Investigational molecules
Locations
7600c The Quorum, Alec Issigonis Way, Arc Oxford, OX4 2UD, United Kingdom
Accession Therapeutics Limited focuses on developing innovative treatments for cancer, with particular emphasis on addressing challenging malignancies. The company's research efforts are directed toward discovering novel therapeutic approaches that target specific cancer types and advance precision medicine in oncology.
The sponsor's work in oncological research reflects a commitment to addressing unmet medical needs in cancer treatment, exploring mechanisms that may offer improved outcomes for patients with specific tumor types. Their investigations span various aspects of cancer biology and therapeutic intervention strategies.
Accession Therapeutics Limited runs clinical trials in conditions such as Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
